IS2421B - Nýir etónógestrel esterar - Google Patents

Nýir etónógestrel esterar

Info

Publication number
IS2421B
IS2421B IS7528A IS7528A IS2421B IS 2421 B IS2421 B IS 2421B IS 7528 A IS7528 A IS 7528A IS 7528 A IS7528 A IS 7528A IS 2421 B IS2421 B IS 2421B
Authority
IS
Iceland
Prior art keywords
new
etonogestrel esters
esters
new etonogestrel
etonogestrel
Prior art date
Application number
IS7528A
Other languages
English (en)
Other versions
IS7528A (is
Inventor
De Nijs Henrik
Adrianus Antonius Van Der Voort Hendrikus
Leysen Dirk
Jan Grootenhuis Arij
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of IS7528A publication Critical patent/IS7528A/is
Publication of IS2421B publication Critical patent/IS2421B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7528A 2002-05-30 2004-11-15 Nýir etónógestrel esterar IS2421B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077119 2002-05-30
PCT/EP2003/050187 WO2003102012A2 (en) 2002-05-30 2003-05-22 New etonogestrel esters

Publications (2)

Publication Number Publication Date
IS7528A IS7528A (is) 2004-11-15
IS2421B true IS2421B (is) 2008-10-15

Family

ID=29595014

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7528A IS2421B (is) 2002-05-30 2004-11-15 Nýir etónógestrel esterar

Country Status (31)

Country Link
US (1) US7323454B2 (is)
EP (1) EP1513861B1 (is)
JP (1) JP4716726B2 (is)
KR (1) KR20050009723A (is)
CN (2) CN1314701C (is)
AR (1) AR040130A1 (is)
AT (1) ATE349458T1 (is)
AU (1) AU2003238081B2 (is)
BR (1) BR0311254A (is)
CA (1) CA2487722C (is)
CO (1) CO5631449A2 (is)
DE (1) DE60310714T2 (is)
DK (1) DK1513861T3 (is)
ES (1) ES2277085T3 (is)
HK (1) HK1072609A1 (is)
HR (1) HRP20041101A2 (is)
IL (1) IL165087A0 (is)
IS (1) IS2421B (is)
MX (1) MXPA04011797A (is)
NO (1) NO20044898L (is)
NZ (1) NZ536619A (is)
PE (1) PE20040068A1 (is)
PL (1) PL373855A1 (is)
PT (1) PT1513861E (is)
RS (1) RS97604A (is)
RU (1) RU2325910C2 (is)
SI (1) SI1513861T1 (is)
TW (1) TW200403065A (is)
UA (1) UA80126C2 (is)
WO (1) WO2003102012A2 (is)
ZA (1) ZA200410410B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters
EP1909973B1 (en) 2005-07-15 2018-08-22 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
US8852625B2 (en) 2006-04-26 2014-10-07 Micell Technologies, Inc. Coatings containing multiple drugs
CN101711137B (zh) 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US9433516B2 (en) 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
CA2721832C (en) 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents having bioabsorbable layers
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
JP2011528275A (ja) 2008-07-17 2011-11-17 ミセル テクノロジーズ,インク. 薬物送達医療デバイス
EP2411083A4 (en) 2009-03-23 2013-11-13 Micell Technologies Inc MEDICAL DEVICE FOR DELIVERY OF MEDICAMENT
CN102481195B (zh) 2009-04-01 2015-03-25 米歇尔技术公司 涂覆支架
EP2531140B1 (en) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EP2593039B1 (en) 2010-07-16 2022-11-30 Micell Technologies, Inc. Drug delivery medical device
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
WO2014165264A1 (en) 2013-03-12 2014-10-09 Micell Technologies, Inc. Bioabsorbable biomedical implants
KR102079613B1 (ko) 2013-05-15 2020-02-20 미셀 테크놀로지즈, 인코포레이티드 생흡수성 생체의학적 임플란트
RU2595818C1 (ru) * 2015-05-25 2016-08-27 Федеральное государственное бюджетное научное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Способ комплексного лечения дисфункции яичников при применении гормонального контрацептива имплантата "импланона"
CN111057120B (zh) * 2019-12-27 2021-04-27 苏州翔实医药发展有限公司 一种依托孕烯衍生物a及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB845442A (en) 1956-03-22 1960-08-24 Schering Ag Manufacture of steroid compounds
DE1013284B (de) 1956-03-22 1957-08-08 Schering Ag Verfahren zur Einfuehrung der Reste wenig reaktionsfaehiger Carbonsaeuren, insbesondere des ª‰-Cyclopentyl-propionylrestes, in die 17ª‡-staendige Oxygruppe solcher Steroide, die am Kohlenstoffatom 17 neben der Oxygruppe eine Acetylgruppe tragen
GB8313921D0 (en) 1983-05-19 1983-06-22 World Health Org Contraceptive compositions
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4240806A1 (de) 1992-12-01 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
JPH07101884A (ja) 1993-10-01 1995-04-18 Sanei Gen F F I Inc 水溶性ヘミセルロースを含有する製剤
CA2176824A1 (en) * 1993-12-27 1995-07-06 Hiroshi Kuroda Percutaneously absorbable preparation
DE19613698A1 (de) 1995-07-17 1997-01-23 Schering Ag Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
EP0848620A1 (de) * 1995-07-17 1998-06-24 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel
WO1999067270A1 (en) 1998-06-19 1999-12-29 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
CZ293319B6 (cs) 1998-06-19 2004-04-14 Akzo Nobel N. V. Derivát testosteronu a farmaceutický prostředek s jeho obsahem
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception
TW200400041A (en) * 2002-05-30 2004-01-01 Akzo Nobel Nv Use of new etonogestrel esters

Also Published As

Publication number Publication date
TW200403065A (en) 2004-03-01
RS97604A (en) 2006-10-27
AU2003238081B2 (en) 2008-09-18
CA2487722C (en) 2011-07-19
DE60310714T2 (de) 2007-10-11
AU2003238081A1 (en) 2003-12-19
ATE349458T1 (de) 2007-01-15
US20050222113A1 (en) 2005-10-06
ZA200410410B (en) 2006-02-22
NO20044898L (no) 2005-02-25
RU2004138807A (ru) 2005-05-27
IL165087A0 (en) 2005-12-18
ES2277085T3 (es) 2007-07-01
WO2003102012A9 (en) 2005-01-13
CN101100480A (zh) 2008-01-09
SI1513861T1 (sl) 2007-06-30
DK1513861T3 (da) 2007-04-10
CN1314701C (zh) 2007-05-09
MXPA04011797A (es) 2005-03-31
EP1513861A2 (en) 2005-03-16
BR0311254A (pt) 2005-03-15
US7323454B2 (en) 2008-01-29
UA80126C2 (en) 2007-08-27
CN1692122A (zh) 2005-11-02
PT1513861E (pt) 2007-03-30
HRP20041101A2 (en) 2004-12-31
NZ536619A (en) 2007-09-28
PE20040068A1 (es) 2004-02-18
DE60310714D1 (de) 2007-02-08
KR20050009723A (ko) 2005-01-25
JP2005532350A (ja) 2005-10-27
IS7528A (is) 2004-11-15
HK1072609A1 (en) 2005-09-02
WO2003102012A2 (en) 2003-12-11
PL373855A1 (en) 2005-09-19
CO5631449A2 (es) 2006-04-28
RU2325910C2 (ru) 2008-06-10
JP4716726B2 (ja) 2011-07-06
AR040130A1 (es) 2005-03-16
EP1513861B1 (en) 2006-12-27
CA2487722A1 (en) 2003-12-11
WO2003102012A3 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
HK1072609A1 (en) New etonogestrel esters
DE50313647D1 (de) Knochenfixationseinrichtumg
NO20044776L (no) Quinolinonderivater
NO20043547L (no) Aza-arylpiperaziner
DE50310866D1 (de) Flanschverbindung
DE60226008D1 (de) Sicherheitsgurtpresentiereinrichtung
DE60331717D1 (de) Zündunterbrecherschaltkreis
IS7563A (is) Sýanógúanidínforlyf
FI20021957A0 (fi) Lipeäruisku
NO20044360L (no) Gasstilforselsystem
DE60321850D1 (de) Hochfrequenzfilterresonator
IS7537A (is) Notkun á nýjum etónógestrel esterum.
DE50214840D1 (de) Ethylestern
DE50308979D1 (de) Einspritzventil
ITMI20021327A1 (it) Nuove ossialchilpiperazine
DE50209283D1 (de) Tropfbewässerungsrohr
DE60205924T2 (de) Mikrogreifer
FIU20020387U0 (fi) Hirrentyöstöyksikkö
NO20043433L (no) Fremgangsmate
DE50311554D1 (de) Filterhalter
SE0203028L (sv) Mätbrunn
DE60219966D1 (de) Virtuelles kegeln
FI5541U1 (fi) Sauna-alusta
FI5460U1 (fi) Rappuaskelma
FI5666U1 (fi) Tomaattileukkuri